Clin Osteol 2006; 11(4): 91-94

Bone disease at late manifestation of gluten sensitive enteropathy - two case reportsReview articles

H. Ciferská, P. Horák, M. Tichý

Gluten sensitive enteropathy also known as coeliac sprue (CS) is an inflammatory disease of the small intestine, mainly jejunum, caused by intolerance of gliadin, a gluten protein, in genetically predisposed individuals. The first manifestation of CS is rare in the adults, more affected are women. The late onset manifestation is often overlooked due to incomplete clinical manifestations or misinterpretation to a different disease. Typical form of CS is mani­ fested in childhood by severe diarrhea, steatorrhea and malabsorbtion symptoms. There are present various stages of atrophy of small intestine architec­ ture present and serological presences of specific antibodies as are against tissue transglutaminase, anti-gliadin antibodies and anti-endomysial antibodi­ es. Osteomalacia and secondary hyperparathyreodism, osteopenia, osteoporosis can be first symptoms of late onset CS. Two case reports show the affection of bone as the first manifestation of CS in adulthood and point out the importance of CS as the one of the cause of metabolic bone diseases.

Keywords: coeliac sprue, gluten entheropathy, osteopenia, osteoporosis

Published: December 11, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ciferská H, Horák P, Tichý M. Bone disease at late manifestation of gluten sensitive enteropathy - two case reports. Osteologický bulletin. 2006;11(4):91-94.
Download citation

References

  1. Mihál V et al: Vybrané kapitoly z pediatrie, VUP Olomouc 2000;75-83.
  2. Frič P. Celiakální sprue - aktuální přehled. Vnitř Lék. 2003
  3. Mařatka Z. Gastroenterologie, Karolinum 1999;207-212.
  4. Maki M, Colin P: Coeliac disease, Lancet 1997;349:1755-1759. Go to original source...
  5. Alaedini A, Green PHR: Narrative Review: Celiac Disea plex autoimune disorder, Ann Intern Med 2005;42:289-298. Go to original source...
  6. Ravelli A, Bolognini S, Gambarotti M et al.: Variability ofhistologic lesions in lation to biopsy site in gluten-sensitive enteropathy, Am J Gastroenterol 2005;100: 177-85. Go to original source...
  7. Dvořák M. Glutenová enteropatie - výskyt, diagnostika Čas Lek Česk. 2005;144 Suppl 1:48-51.
  8. Collin P, Reunala T. Recognition and management of the cutaneous manifesta­ tions of celiac disease: a guide for dermatologists. Am J Clin Dermatol. 2003;4: 13-20. Go to original source...
  9. Kumar P, Clark M. Clinical Medicine, 4th Ed., Harcourt Brace and Company li­ mited 1998;254-256.
  10. Hill ID, Dirks MH, Liptak GS, Colletti RB, Fasano A, Guandalini S, Hoffenberg EJ, Horvath K, Murray JA, Pivor M, Seidman EG; North American Society for Pe­ diatric Gastroenterology, Hepatology and Nutrition. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North Ame­ rican Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Jfediatr Gastroenterol Nutr. 2005;40:1-19. Go to original source...
  11. Ciclitira P^ul J. AGA Technical review on Celiac sprue, Gastroenterology 2001; 120:526-40. Go to original source...
  12. Tommasini A, Not T, Kiren V, Baldas V et al.: Mass screening for coeliac disea­ se using antihuman transglutaminase antibody assay Arch Dis Child 2004;89: 512-515. Go to original source...
  13. Meijer JW, Mulder CJ, Goerres MG, Boot H, Schweizer JJ. Coeliac disease and (extra)intestinal T-cell lymphomas: definition, diagnosis and treatment. Scand J Gastroenterol Suppl. 2004;78-84. Go to original source...
  14. Sategna-Guidetti C, Grosso S B, Grosso S et al.: The effect of 1-year withdrawal on bone mass, bone metabolism and nutrional status in newly-diagnosed adult coeliac disease patients, Aliment Pharmacol Ther 2000;14:35-43. Go to original source...
  15. Thomason K, West J, Logan R F A et al: Fracture experience of patients with coeliac disease: a population based survey Gut 2003;52:518-522. Go to original source...




Clinical Osteology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.